Abiopharma

🔍 McKay Christopher J. (Executive)

Company: OppFi Inc. (OPFI)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Sold 77,850 shares of Class A Common Stock at $7.1779 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 1,431,479.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares sold to satisfy tax liability upon the vesting of restricted stock units and the April 28, 2026 corporate simplification of the issuer.
• F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions with prices ranging from $7.07 to $7.34 for a weighted average sale price of $7.1779. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.